UCA1 and cancer: The overexpression of UCA1 is linked to resistance to chemotherapeutic agents like cisplatin and gemcitabine [141,142], and targeting UCA1 through knockdown strategies has been shown to restore drug sensitivity in resistant cancer cells [143].